Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2023-02-17 Regulatory Filings
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Siemens Healthineers Collaboration
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 2022Q' and contains standard regulatory boilerplate language at the end referencing 'RNS, the news service of the London Stock Exchange' and the 'Financial Conduct Authority'. The content itself is an announcement regarding a collaboration between Oncimmune and Siemens Healthineers concerning lung cancer risk assessment. This is a general corporate announcement released via the Regulatory News Service (RNS). Since it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, CAP, DIRS), the most appropriate classification is the general regulatory announcement category.
2023-02-17 English
Notice of AGM
AGM Information Classification · 98% confidence The document explicitly states 'Notice of Annual General Meeting' and provides the date, time, and location for the AGM. This directly relates to the Annual General Meeting information. Although it is distributed via RNS (London Stock Exchange news service), the core subject matter is the AGM notice, making 'AGM-R' the most specific and appropriate classification over the general 'RNS' fallback. The document length is short (2165 chars), but it is the notice itself, not just an announcement that the notice is available, although it mentions the notice will be sent to shareholders.
2023-02-03 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is a short announcement (2907 characters) released via RNS (London Stock Exchange news service). The title is "Revised notice of audited results (15 months to 31 August 2022)". The core content states that the company "announces that it is now expecting to release its audited results for the 15 months to 31 August 2022 by the end of February 2023". This is not the actual audited results report itself, but an announcement about the *timing* of the release of those results. According to Rule 2, when a document is short and announces the publication of another report, it should be classified as a Report Publication Announcement (RPA). Although it is an RNS filing, RPA is more specific for announcements about report timing.
2023-01-31 English
Appointment of Non-Executive Director
Board/Management Information Classification · 99% confidence The document is an official announcement disseminated via RNS (RNS Number : 5860M) on January 13, 2023. The core subject is the 'Appointment of Non-Executive Director' and includes required disclosures under AIM Rules regarding the director's details, current/previous directorships, and shareholding. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the specific content is not a general regulatory filing or a report publication announcement, but a specific management change disclosure.
2023-01-13 English
ImmunoINSIGHTS Trading Update
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number : 2376K' and contains information typical of a regulatory news service announcement, including the date, company name, and details about new commercial contracts signed (MSA with a top 10 pharmaceutical group). The closing section explicitly mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a general regulatory announcement that does not fit into the more specific categories like 10-K, ER, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (5742 chars) is substantial enough that it is not merely an announcement of a report, but the report itself (a news release).
2022-12-20 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an RNS announcement from Oncimmune Holdings PLC dated December 19, 2022. The primary content revolves around 'Director/PDMR Dealings' following a Capital Raising, detailing share subscriptions by directors (Alistair Macdonald and Tim Bunting). It also includes two TR-1 forms, which are standard notifications of major shareholdings (crossing thresholds) required under UK Market Abuse Regulation, specifically reporting changes in voting rights for Timothy Brian Bunting and Dr Adam M Hill. Since the core subject is the reporting of personal share transactions by directors (insider trades) and notifications of changes in major shareholdings, the most specific applicable codes are 'DIRS' (Director's Dealing) and 'MRQ' (Major Shareholding Notification). Given that the document explicitly details the transactions by PDMRs (Persons Discharging Managerial Responsibilities) and includes the required TR-1 forms for major holdings, 'DIRS' is the most precise classification for the primary action described, although 'MRQ' is also highly relevant. Since 'DIRS' covers insider trades by directors, which is a key component here, I will select DIRS. The document is a regulatory filing announcing these specific events, not a general regulatory filing (RNS) or a general announcement of a report (RPA).
2022-12-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.